Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
34
COSM Quote, Financials, Valuation and Earnings
Last price:
$0.51
Seasonality move
:
-8.53%
Day range:
$0.51 - $0.54
52-week range:
$0.28 - $1.32
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.24x
P/B ratio:
0.79x
Volume:
149.5K
Avg. volume:
564.2K
1-year change:
-20.27%
Market cap:
$18.4M
Revenue:
$54.4M
EPS (TTM):
-$0.71
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
COSM
Cosmos Health, Inc.
|
$14.5M | -$0.09 | -8.46% | -94.8% | $3.00 |
|
ENMI
DH Enchantment, Inc.
|
-- | -- | -- | -- | -- |
|
GEGP
Gold Entertainment Group, Inc.
|
-- | -- | -- | -- | -- |
|
LAB
Standard BioTools, Inc.
|
$18M | -$0.02 | -60.4% | -72.53% | $1.65 |
|
YJGJ
Yijia Group Corp.
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
COSM
Cosmos Health, Inc.
|
$0.53 | $3.00 | $18.4M | -- | $0.00 | 0% | 0.24x |
|
ENMI
DH Enchantment, Inc.
|
$0.0001 | -- | $383.1K | -- | $0.00 | 0% | 0.29x |
|
GEGP
Gold Entertainment Group, Inc.
|
$0.0002 | -- | $1.8M | -- | $0.00 | 0% | 6.01x |
|
LAB
Standard BioTools, Inc.
|
$1.47 | $1.65 | $565.3M | -- | $0.00 | 0% | 4.32x |
|
YJGJ
Yijia Group Corp.
|
$1.61 | -- | $40.3M | 46.67x | $0.00 | 0% | 14.42x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
COSM
Cosmos Health, Inc.
|
51.13% | 3.840 | 68.41% | 1.30x |
|
ENMI
DH Enchantment, Inc.
|
220.68% | 6.029 | 9.65% | 1.00x |
|
GEGP
Gold Entertainment Group, Inc.
|
-- | 192.593 | -- | -- |
|
LAB
Standard BioTools, Inc.
|
6.41% | 0.589 | 5.49% | 1.93x |
|
YJGJ
Yijia Group Corp.
|
-- | 7.232 | -- | 4.89x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
COSM
Cosmos Health, Inc.
|
$2.2M | -$1.8M | -44.07% | -68.76% | -10.63% | -$4M |
|
ENMI
DH Enchantment, Inc.
|
$132K | -$82.8K | -1574.1% | -- | -21.29% | -$71.4K |
|
GEGP
Gold Entertainment Group, Inc.
|
-- | -- | -- | -- | -- | -- |
|
LAB
Standard BioTools, Inc.
|
$9.5M | -$23.5M | -22.34% | -24.44% | -120.02% | -$23.1M |
|
YJGJ
Yijia Group Corp.
|
$260.8K | $99.2K | 54.33% | 55.22% | 23.23% | $212.7K |
Cosmos Health, Inc. vs. Competitors
-
Which has Higher Returns COSM or ENMI?
DH Enchantment, Inc. has a net margin of -31.29% compared to Cosmos Health, Inc.'s net margin of -32.22%. Cosmos Health, Inc.'s return on equity of -68.76% beat DH Enchantment, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital COSMCosmos Health, Inc.13% -$0.17 $47.3M ENMIDH Enchantment, Inc.34.06% -- $1.4M -
What do Analysts Say About COSM or ENMI?
Cosmos Health, Inc. has a consensus price target of $3.00, signalling upside risk potential of 470.34%. On the other hand DH Enchantment, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Cosmos Health, Inc. has higher upside potential than DH Enchantment, Inc., analysts believe Cosmos Health, Inc. is more attractive than DH Enchantment, Inc..
Company Buy Ratings Hold Ratings Sell Ratings COSMCosmos Health, Inc.0 0 0 ENMIDH Enchantment, Inc.0 0 0 -
Is COSM or ENMI More Risky?
Cosmos Health, Inc. has a beta of 4.381, which suggesting that the stock is 338.129% more volatile than S&P 500. In comparison DH Enchantment, Inc. has a beta of 2.427, suggesting its more volatile than the S&P 500 by 142.707%.
-
Which is a Better Dividend Stock COSM or ENMI?
Cosmos Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. DH Enchantment, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cosmos Health, Inc. pays -- of its earnings as a dividend. DH Enchantment, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios COSM or ENMI?
Cosmos Health, Inc. quarterly revenues are $17.1M, which are larger than DH Enchantment, Inc. quarterly revenues of $387.6K. Cosmos Health, Inc.'s net income of -$5.4M is lower than DH Enchantment, Inc.'s net income of -$124.9K. Notably, Cosmos Health, Inc.'s price-to-earnings ratio is -- while DH Enchantment, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cosmos Health, Inc. is 0.24x versus 0.29x for DH Enchantment, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income COSMCosmos Health, Inc.0.24x -- $17.1M -$5.4M ENMIDH Enchantment, Inc.0.29x -- $387.6K -$124.9K
-
Which has Higher Returns COSM or GEGP?
Gold Entertainment Group, Inc. has a net margin of -31.29% compared to Cosmos Health, Inc.'s net margin of --. Cosmos Health, Inc.'s return on equity of -68.76% beat Gold Entertainment Group, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital COSMCosmos Health, Inc.13% -$0.17 $47.3M GEGPGold Entertainment Group, Inc.-- -- -- -
What do Analysts Say About COSM or GEGP?
Cosmos Health, Inc. has a consensus price target of $3.00, signalling upside risk potential of 470.34%. On the other hand Gold Entertainment Group, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Cosmos Health, Inc. has higher upside potential than Gold Entertainment Group, Inc., analysts believe Cosmos Health, Inc. is more attractive than Gold Entertainment Group, Inc..
Company Buy Ratings Hold Ratings Sell Ratings COSMCosmos Health, Inc.0 0 0 GEGPGold Entertainment Group, Inc.0 0 0 -
Is COSM or GEGP More Risky?
Cosmos Health, Inc. has a beta of 4.381, which suggesting that the stock is 338.129% more volatile than S&P 500. In comparison Gold Entertainment Group, Inc. has a beta of 22.515, suggesting its more volatile than the S&P 500 by 2151.46%.
-
Which is a Better Dividend Stock COSM or GEGP?
Cosmos Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Gold Entertainment Group, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cosmos Health, Inc. pays -- of its earnings as a dividend. Gold Entertainment Group, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios COSM or GEGP?
Cosmos Health, Inc. quarterly revenues are $17.1M, which are larger than Gold Entertainment Group, Inc. quarterly revenues of --. Cosmos Health, Inc.'s net income of -$5.4M is higher than Gold Entertainment Group, Inc.'s net income of --. Notably, Cosmos Health, Inc.'s price-to-earnings ratio is -- while Gold Entertainment Group, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cosmos Health, Inc. is 0.24x versus 6.01x for Gold Entertainment Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income COSMCosmos Health, Inc.0.24x -- $17.1M -$5.4M GEGPGold Entertainment Group, Inc.6.01x -- -- --
-
Which has Higher Returns COSM or LAB?
Standard BioTools, Inc. has a net margin of -31.29% compared to Cosmos Health, Inc.'s net margin of -162.05%. Cosmos Health, Inc.'s return on equity of -68.76% beat Standard BioTools, Inc.'s return on equity of -24.44%.
Company Gross Margin Earnings Per Share Invested Capital COSMCosmos Health, Inc.13% -$0.17 $47.3M LABStandard BioTools, Inc.48.51% -$0.09 $427M -
What do Analysts Say About COSM or LAB?
Cosmos Health, Inc. has a consensus price target of $3.00, signalling upside risk potential of 470.34%. On the other hand Standard BioTools, Inc. has an analysts' consensus of $1.65 which suggests that it could grow by 5.44%. Given that Cosmos Health, Inc. has higher upside potential than Standard BioTools, Inc., analysts believe Cosmos Health, Inc. is more attractive than Standard BioTools, Inc..
Company Buy Ratings Hold Ratings Sell Ratings COSMCosmos Health, Inc.0 0 0 LABStandard BioTools, Inc.1 2 0 -
Is COSM or LAB More Risky?
Cosmos Health, Inc. has a beta of 4.381, which suggesting that the stock is 338.129% more volatile than S&P 500. In comparison Standard BioTools, Inc. has a beta of 1.236, suggesting its more volatile than the S&P 500 by 23.585%.
-
Which is a Better Dividend Stock COSM or LAB?
Cosmos Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Standard BioTools, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cosmos Health, Inc. pays -- of its earnings as a dividend. Standard BioTools, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios COSM or LAB?
Cosmos Health, Inc. quarterly revenues are $17.1M, which are smaller than Standard BioTools, Inc. quarterly revenues of $19.6M. Cosmos Health, Inc.'s net income of -$5.4M is higher than Standard BioTools, Inc.'s net income of -$31.7M. Notably, Cosmos Health, Inc.'s price-to-earnings ratio is -- while Standard BioTools, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cosmos Health, Inc. is 0.24x versus 4.32x for Standard BioTools, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income COSMCosmos Health, Inc.0.24x -- $17.1M -$5.4M LABStandard BioTools, Inc.4.32x -- $19.6M -$31.7M
-
Which has Higher Returns COSM or YJGJ?
Yijia Group Corp. has a net margin of -31.29% compared to Cosmos Health, Inc.'s net margin of 8.38%. Cosmos Health, Inc.'s return on equity of -68.76% beat Yijia Group Corp.'s return on equity of 55.22%.
Company Gross Margin Earnings Per Share Invested Capital COSMCosmos Health, Inc.13% -$0.17 $47.3M YJGJYijia Group Corp.61.06% $0.00 $1.9M -
What do Analysts Say About COSM or YJGJ?
Cosmos Health, Inc. has a consensus price target of $3.00, signalling upside risk potential of 470.34%. On the other hand Yijia Group Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that Cosmos Health, Inc. has higher upside potential than Yijia Group Corp., analysts believe Cosmos Health, Inc. is more attractive than Yijia Group Corp..
Company Buy Ratings Hold Ratings Sell Ratings COSMCosmos Health, Inc.0 0 0 YJGJYijia Group Corp.0 0 0 -
Is COSM or YJGJ More Risky?
Cosmos Health, Inc. has a beta of 4.381, which suggesting that the stock is 338.129% more volatile than S&P 500. In comparison Yijia Group Corp. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock COSM or YJGJ?
Cosmos Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Yijia Group Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cosmos Health, Inc. pays -- of its earnings as a dividend. Yijia Group Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios COSM or YJGJ?
Cosmos Health, Inc. quarterly revenues are $17.1M, which are larger than Yijia Group Corp. quarterly revenues of $427.1K. Cosmos Health, Inc.'s net income of -$5.4M is lower than Yijia Group Corp.'s net income of $35.8K. Notably, Cosmos Health, Inc.'s price-to-earnings ratio is -- while Yijia Group Corp.'s PE ratio is 46.67x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cosmos Health, Inc. is 0.24x versus 14.42x for Yijia Group Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income COSMCosmos Health, Inc.0.24x -- $17.1M -$5.4M YJGJYijia Group Corp.14.42x 46.67x $427.1K $35.8K
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
